ALL KEYWORDSPeripheral T-Cell LymphomaRelated SpecialistsShowing 3 of 22Francine FossMDTarsheen SethiMD, MScStuart SeropianMDMore Related SpecialistsRelated Clinical TrialsShowing 2 of 4A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)LymphomaSoquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaLymphomaMore Related Clinical Trials
